Cargando…

Understanding the pathogenesis of lean non-autoimmune diabetes in an African population with newly diagnosed diabetes

AIMS/HYPOTHESIS: Apparent type 2 diabetes is increasingly reported in lean adult individuals in sub-Saharan Africa. However, studies undertaking robust clinical and metabolic characterisation of lean individuals with new-onset type 2 diabetes are limited in this population. This cross-sectional stud...

Descripción completa

Detalles Bibliográficos
Autores principales: Kibirige, Davis, Sekitoleko, Isaac, Lumu, William, Jones, Angus G., Hattersley, Andrew T., Smeeth, Liam, Nyirenda, Moffat J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8894297/
https://www.ncbi.nlm.nih.gov/pubmed/35138411
http://dx.doi.org/10.1007/s00125-021-05644-8
_version_ 1784662623684395008
author Kibirige, Davis
Sekitoleko, Isaac
Lumu, William
Jones, Angus G.
Hattersley, Andrew T.
Smeeth, Liam
Nyirenda, Moffat J.
author_facet Kibirige, Davis
Sekitoleko, Isaac
Lumu, William
Jones, Angus G.
Hattersley, Andrew T.
Smeeth, Liam
Nyirenda, Moffat J.
author_sort Kibirige, Davis
collection PubMed
description AIMS/HYPOTHESIS: Apparent type 2 diabetes is increasingly reported in lean adult individuals in sub-Saharan Africa. However, studies undertaking robust clinical and metabolic characterisation of lean individuals with new-onset type 2 diabetes are limited in this population. This cross-sectional study aimed to perform a detailed clinical and metabolic characterisation of newly diagnosed adult patients with diabetes in Uganda, in order to compare features between lean and non-lean individuals. METHODS: Socio-demographic, clinical, biophysical and metabolic (including oral glucose tolerance test) data were collected on 568 adult patients with newly diagnosed diabetes. Participants were screened for islet autoantibodies to exclude those with autoimmune diabetes. The remaining participants (with type 2 diabetes) were then classified as lean (BMI <25 kg/m(2)) or non-lean (BMI ≥25 kg/m(2)), and their socio-demographic, clinical, biophysical and metabolic characteristics were compared. RESULTS: Thirty-four participants (6.4%) were excluded from analyses because they were positive for pancreatic autoantibodies, and a further 34 participants because they had incomplete data. For the remaining 500 participants, the median (IQR) age, BMI and HbA(1c) were 48 years (39–58), 27.5 kg/m(2) (23.6–31.4) and 90 mmol/mol (61–113) (10.3% [7.7–12.5]), respectively, with a female predominance (approximately 57%). Of the 500 participants, 160 (32%) and 340 (68%) were lean and non-lean, respectively. Compared with non-lean participants, lean participants were mainly male (60.6% vs 35.3%, p<0.001) and had lower visceral adiposity level (5 [4–7] vs 11 [9–13], p<0.001) and features of the metabolic syndrome (uric acid, 246.5 [205.0–290.6] vs 289 [234–347] μmol/l, p<0.001; leptin, 660.9 [174.5–1993.1] vs 3988.0 [1336.0–6595.0] pg/ml, p<0.001). In addition, they displayed markedly reduced markers of beta cell function (oral insulinogenic index 0.8 [0.3–2.5] vs 1.6 [0.6–4.6] pmol/mmol; 120 min serum C-peptide 0.70 [0.33–1.36] vs 1.02 [0.60–1.66] nmol/l, p<0.001). CONCLUSIONS/INTERPRETATION: Approximately one-third of participants with incident adult-onset non-autoimmune diabetes had BMI <25 kg/m(2). Diabetes in these lean individuals was more common in men, and predominantly associated with reduced pancreatic secretory function rather than insulin resistance. The underlying pathological mechanisms are unclear, but this is likely to have important management implications. GRAPHICAL ABSTRACT: [Image: see text]
format Online
Article
Text
id pubmed-8894297
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Springer Berlin Heidelberg
record_format MEDLINE/PubMed
spelling pubmed-88942972022-03-08 Understanding the pathogenesis of lean non-autoimmune diabetes in an African population with newly diagnosed diabetes Kibirige, Davis Sekitoleko, Isaac Lumu, William Jones, Angus G. Hattersley, Andrew T. Smeeth, Liam Nyirenda, Moffat J. Diabetologia Article AIMS/HYPOTHESIS: Apparent type 2 diabetes is increasingly reported in lean adult individuals in sub-Saharan Africa. However, studies undertaking robust clinical and metabolic characterisation of lean individuals with new-onset type 2 diabetes are limited in this population. This cross-sectional study aimed to perform a detailed clinical and metabolic characterisation of newly diagnosed adult patients with diabetes in Uganda, in order to compare features between lean and non-lean individuals. METHODS: Socio-demographic, clinical, biophysical and metabolic (including oral glucose tolerance test) data were collected on 568 adult patients with newly diagnosed diabetes. Participants were screened for islet autoantibodies to exclude those with autoimmune diabetes. The remaining participants (with type 2 diabetes) were then classified as lean (BMI <25 kg/m(2)) or non-lean (BMI ≥25 kg/m(2)), and their socio-demographic, clinical, biophysical and metabolic characteristics were compared. RESULTS: Thirty-four participants (6.4%) were excluded from analyses because they were positive for pancreatic autoantibodies, and a further 34 participants because they had incomplete data. For the remaining 500 participants, the median (IQR) age, BMI and HbA(1c) were 48 years (39–58), 27.5 kg/m(2) (23.6–31.4) and 90 mmol/mol (61–113) (10.3% [7.7–12.5]), respectively, with a female predominance (approximately 57%). Of the 500 participants, 160 (32%) and 340 (68%) were lean and non-lean, respectively. Compared with non-lean participants, lean participants were mainly male (60.6% vs 35.3%, p<0.001) and had lower visceral adiposity level (5 [4–7] vs 11 [9–13], p<0.001) and features of the metabolic syndrome (uric acid, 246.5 [205.0–290.6] vs 289 [234–347] μmol/l, p<0.001; leptin, 660.9 [174.5–1993.1] vs 3988.0 [1336.0–6595.0] pg/ml, p<0.001). In addition, they displayed markedly reduced markers of beta cell function (oral insulinogenic index 0.8 [0.3–2.5] vs 1.6 [0.6–4.6] pmol/mmol; 120 min serum C-peptide 0.70 [0.33–1.36] vs 1.02 [0.60–1.66] nmol/l, p<0.001). CONCLUSIONS/INTERPRETATION: Approximately one-third of participants with incident adult-onset non-autoimmune diabetes had BMI <25 kg/m(2). Diabetes in these lean individuals was more common in men, and predominantly associated with reduced pancreatic secretory function rather than insulin resistance. The underlying pathological mechanisms are unclear, but this is likely to have important management implications. GRAPHICAL ABSTRACT: [Image: see text] Springer Berlin Heidelberg 2022-02-09 2022 /pmc/articles/PMC8894297/ /pubmed/35138411 http://dx.doi.org/10.1007/s00125-021-05644-8 Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) .
spellingShingle Article
Kibirige, Davis
Sekitoleko, Isaac
Lumu, William
Jones, Angus G.
Hattersley, Andrew T.
Smeeth, Liam
Nyirenda, Moffat J.
Understanding the pathogenesis of lean non-autoimmune diabetes in an African population with newly diagnosed diabetes
title Understanding the pathogenesis of lean non-autoimmune diabetes in an African population with newly diagnosed diabetes
title_full Understanding the pathogenesis of lean non-autoimmune diabetes in an African population with newly diagnosed diabetes
title_fullStr Understanding the pathogenesis of lean non-autoimmune diabetes in an African population with newly diagnosed diabetes
title_full_unstemmed Understanding the pathogenesis of lean non-autoimmune diabetes in an African population with newly diagnosed diabetes
title_short Understanding the pathogenesis of lean non-autoimmune diabetes in an African population with newly diagnosed diabetes
title_sort understanding the pathogenesis of lean non-autoimmune diabetes in an african population with newly diagnosed diabetes
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8894297/
https://www.ncbi.nlm.nih.gov/pubmed/35138411
http://dx.doi.org/10.1007/s00125-021-05644-8
work_keys_str_mv AT kibirigedavis understandingthepathogenesisofleannonautoimmunediabetesinanafricanpopulationwithnewlydiagnoseddiabetes
AT sekitolekoisaac understandingthepathogenesisofleannonautoimmunediabetesinanafricanpopulationwithnewlydiagnoseddiabetes
AT lumuwilliam understandingthepathogenesisofleannonautoimmunediabetesinanafricanpopulationwithnewlydiagnoseddiabetes
AT jonesangusg understandingthepathogenesisofleannonautoimmunediabetesinanafricanpopulationwithnewlydiagnoseddiabetes
AT hattersleyandrewt understandingthepathogenesisofleannonautoimmunediabetesinanafricanpopulationwithnewlydiagnoseddiabetes
AT smeethliam understandingthepathogenesisofleannonautoimmunediabetesinanafricanpopulationwithnewlydiagnoseddiabetes
AT nyirendamoffatj understandingthepathogenesisofleannonautoimmunediabetesinanafricanpopulationwithnewlydiagnoseddiabetes